Frank Steven Insider Trades

Insider Trading History

Track insider trading activity for Frank Steven. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $330k 35,459 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$415k 48,834 shares
$8.50
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $188k 20,165 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 1,262 shares
$8.91
$9.31
Precigen
Precigen PGEN
Director
Holding Value $6.57M 1,226,391 shares
Last Trade
Mar 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$252k 71,839 shares
$3.51
$5.36
Precigen
Precigen PGEN
Director
Holding Value $0 0 shares
Last Trade
Mar 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$252k 71,839 shares
$3.51
$5.36
Precigen
Precigen PGEN
Director
Holding Value $6.19M 1,154,552 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$319k 90,930 shares
$3.51
$5.36
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $176k 18,903 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 1,285 shares
$8.75
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $164k 17,618 shares
Last Trade
Nov 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 1,566 shares
$7.18
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $149k 16,052 shares
Last Trade
Aug 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 1,353 shares
$8.31
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $253k 27,181 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$283k 27,181 shares
$10.40
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $20.5k 2,199 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.58k 333 shares
$10.75
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $38k 4,079 shares
Last Trade
May 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.4k 4,079 shares
$8.93
$9.31
Precigen
Precigen PGEN
Director
Holding Value $0 0 shares
Last Trade
Mar 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$157k 87,412 shares
$1.80
$5.36
Precigen
Precigen PGEN
Director
Holding Value $6.11M 1,140,307 shares
Last Trade
Mar 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$157k 87,412 shares
$1.80
$5.36
Precigen
Precigen PGEN
Director
Holding Value $5.64M 1,052,895 shares
Last Trade
Mar 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 112,252 shares
$1.74
$5.36
Precigen
Precigen PGEN
Director
Holding Value $5.49M 1,024,160 shares
Last Trade
Mar 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 136,591 shares
$1.43
$5.36
Precigen
Precigen PGEN
Director
Holding Value $5.3M 989,195 shares
Last Trade
Mar 09, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$187k 106,837 shares
$1.75
$5.36
Precigen
Precigen PGEN
Director
Holding Value $0 0 shares
Last Trade
Mar 09, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$187k 106,837 shares
$1.75
$5.36
Precigen
Precigen PGEN
Director
Holding Value $4.73M 882,358 shares
Last Trade
Aug 14, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$688k 400,000 shares
$1.72
$5.36
Precigen
Precigen PGEN
Director
Holding Value $2.59M 482,358 shares
Last Trade
Mar 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 168,224 shares
$1.17
$5.36
Precigen
Precigen PGEN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.8k 61,576 shares
$1.28
$5.36

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up